{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:55Z","timestamp":1791839875538,"version":"4.3.4"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T00:00:00Z","timestamp":1508025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T00:00:00Z","timestamp":1508025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/dth.12559","type":"journal-article","created":{"date-parts":[[2017,10,15]],"date-time":"2017-10-15T22:36:35Z","timestamp":1508106995000},"page":"e12559","source":"Crossref","is-referenced-by-count":23,"title":["Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation"],"prefix":"10.1155","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-5673","authenticated-orcid":false,"given":"Nolan J.","family":"Maloney","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine at UCLA; Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Hisaw","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine; David Geffen School of Medicine at UCLA; Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Worswick","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine; David Geffen School of Medicine at UCLA; Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,15]]},"reference":[{"issue":"1","key":"10.1111\/dth.12559-BIB0001|dth12559-cit-0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000381011","article-title":"Ustekinumab as an alternative treatment option for chronic pityriasis rubra pilaris","volume":"7","author":"Chowdhary","year":"2015","journal-title":"Case Reports in Dermatology"},{"issue":"1","key":"10.1111\/dth.12559-BIB0002|dth12559-cit-0003","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamadermatol.2013.4773","article-title":"Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center","volume":"150","author":"Eastham","year":"2014","journal-title":"JAMA Dermatology"},{"issue":"8","key":"10.1111\/dth.12559-BIB0003|dth12559-cit-0004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1468-3083.2009.03511.x","article-title":"Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: a case series","volume":"24","author":"Garcovich","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/dth.12559-BIB0004|dth12559-cit-0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis Rubra Pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clinical and Experimental Dermatology"},{"issue":"3","key":"10.1111\/dth.12559-BIB0005|dth12559-cit-0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11530070-000000000-00000","article-title":"Pityriasis rubra pilaris: A review of diagnosis and treatment","volume":"11","author":"Klein","year":"2010","journal-title":"American Journal of Clinical Dermatology"},{"issue":"3","key":"10.1111\/dth.12559-BIB0006|dth12559-cit-0007","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jamadermatol.2015.3405","article-title":"Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast","volume":"152","author":"Krase","year":"2016","journal-title":"JAMA Dermatology"},{"issue":"4","key":"10.1111\/dth.12559-BIB0007|dth12559-cit-0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D39V30410D","article-title":"Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab","volume":"12","author":"Lu","year":"2006","journal-title":"Dermatology Online Journal"},{"issue":"4","key":"10.1111\/dth.12559-BIB0008|dth12559-cit-0009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2336\/nishinihonhifu.76.349","article-title":"Pityriasis rubra pilaris\u202f: Failure of treatment with infliximab","volume":"76","author":"Masuda","year":"2014","journal-title":"Nishi Nihon Hifuka"},{"issue":"1","key":"10.1111\/dth.12559-BIB0009|dth12559-cit-0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1468-3083.2012.04456.x","article-title":"A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists","volume":"27","author":"Petrof","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1111\/dth.12559-BIB0010|dth12559-cit-0011","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2016.0091","article-title":"Epidemiologic, clinicopathologic, diagnostic, and management challenges of pityriasis rubra pilaris: A case series of 100 patients","volume":"152","author":"Ross","year":"2016","journal-title":"JAMA Dermatology"},{"issue":"11","key":"10.1111\/dth.12559-BIB0011|dth12559-cit-0012","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2016.3885","article-title":"Successful treatment of refractory pityriasis rubra pilaris with secukinumab","volume":"152","author":"Schuster","year":"2016","journal-title":"JAMA Dermatology"},{"issue":"6","key":"10.1111\/dth.12559-BIB0012|dth12559-cit-0013","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1684\/ejd.2013.2175","article-title":"Pityriasis rubra pilaris types 1 and 2: different responses to treatment with TNF-alpha antagonists","volume":"23","author":"Vujic","year":"2013","journal-title":"European Journal of Dermatology"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12559\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:57:09Z","timestamp":1671800229000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,15]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12559","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,15]]}}}